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The authors report the case of 46-year-old man with recurrent hemoptysis. Bronchoscopy revealed a submucosal
tumor protruding into the tracheal lumen. Transbronchial biopsy failed to obtain a conclusive diagnosis; only surgery
allowed complete resection of the tumor and confirmed the diagnosis of tracheal mucoepidermoid carcinoma. We
discuss the unusual submucosal presentation of this tumor, and the contribution of surgery for diagnosis and therapy.
Keywords: Trachea, Submucosal glands tumors, Mucoepidermoid carcinoma, Tracheal resection, End-to-end
anastomosisBackground
Tracheal mucoepidermoid carcinoma (MEC) is a rare air-
way tumor and represents, along with the adenoid cystic
carcinoma (ACC), one of the two most common types of
primary salivary-type tracheal tumors. These tumors are
indistinguishable histologically from their salivary gland
counterparts, and it is believed that they originate from
the submucosal glands of the tracheobronchial tree and
probably are related to structural homology between exo-
crine glands. MEC can be divided into low grade and
high grade on the basis of histological criteria. The
most important factors in the prognosis include histo-
logical grading and the ability to achieve a complete
surgical resection [1].
We report a case of a 46-year-old, previously healthy man,
with a submucosal tracheal tumor, in whom transbronchial
biopsies were inconclusive; only surgery allowed removal of
the tumor and confirmed the diagnosis of tracheal MEC. To
our knowledge, such a presentation of this tumor has not
been previously reported.Case presentation
A 46-year-old male smoker presented with a 2-year his-
tory of hemoptysis. On admission, routine laboratory
studies including pulmonary function tests were normal.* Correspondence: smct71@yahoo.fr
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(CT) revealed a 4 × 4 × 3 cm circular mass in the lower third
of the trachea, including the carina and repulsing the arch
of azygous vein (Figure 1). There was no mediastinal lymph-
adenopathy or obvious findings of bronchial invasion. Spiral
CT with multiplanar and three-dimensional reconstructions
predicted the tumor extended to the origin of the right main
bronchus (Figure 2). After further workup, there was no evi-
dence of any metastatic lesion.
A flexible bronchoscopy showed a normal tracheal lumen,
with bulging and erythematous mucosa, on the right pos-
terolateral wall above the carina (Figure 3). Transbronchial
biopsies were inconclusive.
Through a right posterolateral thoracotomy (Figure 4),
the azygous vein was transected and a paratracheal and
subcarinal lymph node dissection was performed. The
tumor appeared to be at the expense of the tracheal wall.
Complete excision of the mass (Figure 5) was performed
by lateral resection of the trachea and reconstruction
was made by end-to-end anastomosis with interrupted
sutures on the cartilaginous part and posterior membrane
of the trachea, using absorbable 4.0 polydioxanone su-
tures, without lung resection (Figure 6). Tracheal anasto-
mosis was buttressed by a pleural flap. Intraoperative
frozen examination revealed a mucoepidermoid tumor of
the trachea with tumor-free surgical margins.
The postoperative course was uncomplicated; chest
drain was removed on the fourth day following surgery.
The final pathologic examination confirmed the diagno-
sis of primary low-grade MEC originating broadly from
the trachea, without the involvement of the surgicaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Computed tomography showed a circular mass in the
lower trachea (arrow), with extra tracheal development.
Figure 3 Fiberoptic bronchoscopy showed a submucosal
tracheal tumor (arrow).
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in the lymph nodes that were excised. Follow-up 1 year
after surgery is normal and the patient is today tumor
free.
Discussion
Tracheal MEC arises from the submucosal glands of the
tracheobronchial tree and probably is related to struc-
ture homology between exocrine glands. It is a rare air-
way tumor, representing 0.2% of all respiratory tumors
and 1 to 5% of ‘bronchial adenomas’, a term that was
used to describe a group of slow-growing neoplasmsFigure 2 Spiral computed tomography showed that the tumor
extended just across the carina (arrow).thought to arise from the bronchial glands, and included
ACC, MEC, mixed tumors and carcinoid tumors [2].
However, it is clear that the group of salivary-type tra-
cheal cancers, dominated by ACC and MEC, comprise a
distinct category of tracheal neoplasms.
Histologically, MEC of the tracheobronchial tree con-
sists of variable proportions of mucus secreting cells,
squamous cells, and so-called intermediate cells that
show no particular differentiating characteristics [2]. The
tumor is histopathologically classified as a low- or high-
grade malignancy. Mitoses, nuclear pleomorphism, and
necrosis are usually absent or minimal (less than five mi-
toses per 50 high-power fields) in low-grade MEC [2]. InFigure 4 Intraoperative view showing the tumor (white arrows)
displacing the arch of the azygous vein (black arrow).
Figure 5 Photograph of the gross pathologic specimen
obtained by angular resection and end-to-end anastomosis of
the trachea, showing a well-circumscribed tumor.
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per 10 high-power fields, and nuclear pleomorphism,
hyperchromasia, and cellular necrosis are present.
Generally, these tumors produce symptoms of upper re-
spiratory tract obstruction, such as cough, dyspnea,
hemoptysis, wheezing, atelectasis or postobstructive pneu-
monia, and it frequently is mistaken for asthma or chronic
pulmonary obstructive disease, with no or partial response
to treatment. When the symptoms are not resolved, a more
scrupulous workup is usually performed and intratracheal
tumors diagnosed.
Imaging studies usually precede bronchoscopy, unless
the patient arrives in respiratory distress. Improvements in
technology now allow CT scanning to provide various
images for airway visualization. As far as diseases involving
the central airways are concerned, the transverse extent of
disease and its relationship to adjacent structures are better
shown on the usual transverse CT sections, but theFigure 6 Diagram illustrating the tracheal resection and anastomosislongitudinal extent of the tumor is better demonstrated on
the multiplanar reconstruction and three-dimensional
images [3]. In the present case, the CT has been of great
help in visualizing the extraluminal portion of the tumor,
allowing us to better prepare the surgical approach.
Patients with malignant tumors undergo a search for meta-
static disease that typically includes examinations of the
lung, brain, bone, adrenal glands, and liver.
Every patient suspected of having a tracheal tumor
should undergo bronchoscopy with biopsy, which re-
mains the main diagnostic modality in nonemergency
cases. MEC often presents as a sessile tracheal tumor.
In the present case, the MEC had an unusual sub-
mucosal presentation, explaining the negative bronchial
biopsies and hence the need for surgery for therapeutic
and diagnostic purposes. This surgery requires an accur-
ate preoperative assessment, including a bronchoscopy
and chest CT with multiplanar tracheal reconstructions.
The usual recommendations of tracheal surgery must be
respected, from the induction of anesthesia until the
resection-anastomosis, without omitting the intraoperative
ventilation technique. A biopsy with frozen section exam-
ination must be performed because the operative strategy
would be affected by the results.
The clinical course of these tumors correlates with the
histological grade of the tumor. Patients with high-grade
lesions have been reported to have a poor prognosis; the
5-year survival rate is 25 to 31% [4]. Low-grade tumors
present localized growth, rarely affect the lymph nodes
and are easily resected, with a normal life expectancy,
and 5-year survival after resection can be as high as 80%
[5]. Lymph node involvement has been reported to be
an indicator of a worse prognosis; only 2% of low-grade
tumors and 15% of high-grade tumors metastasized to
the regional lymph nodes. ACC has a higher likelihood
than MEC to metastasize. Overall, patients with MEC
survive better than patients with ACC.performed.
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cheal rings combined with reconstruction of the trachea
is the mainstay of treatment. The role of radiotherapy
and chemotherapy, before or after surgery, has yet to be
well established [6].
Conclusion
In summary, a tracheal MEC may be submucosal, and the
transbronchial biopsy may remain negative. In this case, sur-
gical excision for diagnostic and therapeutic purposes is pos-
sible, after performing CT with multiplanar reconstructions.
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